×
Aditxt Goodwill and Intangible Assets 2020-2025 | ADTX
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Aditxt goodwill and intangible assets from 2020 to 2025. Goodwill and intangible assets can be defined as the sum of all intangible asset fields
View More
Aditxt Goodwill and Intangible Assets 2020-2025 | ADTX
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Aditxt goodwill and intangible assets from 2020 to 2025. Goodwill and intangible assets can be defined as the sum of all intangible asset fields
Related Stocks
Company Name
Market
Cap
Chugai Pharmaceutical (CHGCY)
$80.2B
Zoetis (ZTS)
$68.3B
Daiichi Sankyo, - (DSNKY)
$47.1B
Takeda Pharmaceutical (TAK)
$46.9B
BeOne Medicines - (ONC)
$32.3B
Sandoz Group AG (SDZNY)
$26.4B
Summit Therapeutics (SMMT)
$20.8B
Merck (MKKGY)
$17.3B
Shionogi (SGIOY)
$14.5B
United Therapeutics (UTHR)
$13.8B
Neurocrine Biosciences (NBIX)
$13.2B
Orion OYJ (ORINY)
$11.7B
IPSEN (IPSEY)
$10.9B
Stevanato Group S.p.A (STVN)
$7.7B
Corcept Therapeutics (CORT)
$7.3B
Madrigal Pharmaceuticals (MDGL)
$6.8B
Grifols, S.A (GRFS)
$6.8B
Ionis Pharmaceuticals (IONS)
$6.7B
Hikma Pharmaceuticals Plc (HKMPF)
$5.9B
Ono Pharmaceutical (OPHLF)
$5.2B
Soleno Therapeutics (SLNO)
$4.4B
Hypermarcas (HYPMY)
$3.1B
Crinetics Pharmaceuticals (CRNX)
$2.9B
NewAmsterdam Pharma (NAMS)
$2.7B
Catalyst Pharmaceuticals (CPRX)
$2.6B
Procaps Group, S.A (PROCF)
$2.5B
AMNEAL PHARMACEUTICALS, INC (AMRX)
$2.5B
Centessa Pharmaceuticals (CNTA)
$2.1B
Ocular Therapeutix (OCUL)
$1.9B
BioCryst Pharmaceuticals (BCRX)
$1.8B